2024/05/13 22:30:01 | |
---|---|
Price | |
0.9685 USD | |
Difference | 4.71% (0.04) |
ISIN | US59564R7089 |
Symbol | BDRX |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 82 EUR |
Benchmark | FTSE 100 |
Bid (Bid size) | 0.96 USD (2,100) |
Ask (Ask size) | 0.9899 USD (100) |
Open | 0.93 USD |
High | 0.99 USD |
Low | 0.9203 USD |
Close (prev. day) | 0.9249 USD |
VWAP | 0.948791 USD |
Volume (pcs) | 106,657 |
Trading volume | 101,210.33 |
Number of trades | 532 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/05/13 22:30:01 | |
---|---|
Price | |
0.9685 USD | |
Difference | 4.71% (0.04) |
ISIN | US59564R7089 |
Symbol | BDRX |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 82 EUR |
Benchmark | FTSE 100 |
Bid (Bid size) | 0.96 USD (2,100) |
Ask (Ask size) | 0.9899 USD (100) |
Open | 0.93 USD |
High | 0.99 USD |
Low | 0.9203 USD |
Close (prev. day) | 0.9249 USD |
VWAP | 0.948791 USD |
Volume (pcs) | 106,657 |
Trading volume | 101,210.33 |
Number of trades | 532 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -58.79% | -94.95% | - |
Perf (abs.) | -1.38 | -18.20 | - |
Beta | 1.74 | 2.22 | 1.17 |
Volatility | 189.79 | 184.97 | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.9786 USD (167,542) |
Ø price 30 days | Ø volume 30 days (pcs.) | 1.0192 USD (2,727,563) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.4937 USD (2,116,399) |
Ø price 250 days | Ø volume 250 days (pcs.) | 3.8741 USD (1,190,515) |
YTD High | date | 2.7400 USD (2024/01/04) |
YTD Low | date | 0.6700 USD (2024/04/25) |
52 Weeks High | date | 20.3920 USD (2023/05/18) |
52 Weeks Low | date | 0.6700 USD (2024/04/25) |
- |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer